Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| FEDERAL MOGU | FDML | 7.44% |
| SUMMER INFAN | SUMR | 6.78% |
| RADIANT LOGI | RLGT | 6.38% |
| NATUS MEDICA | BABY | 5.34% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Despite macroeconomic headwinds, Honeywell International Inc. ( HON - Analyst Report ) reported solid fourth quarter 2012 results with adjusted earnings of $1.10 per share compared to $1.05 in the year-ago quarter. The adjusted earnings for the reported quarter marginally beat the Zacks Consensus Estimate by a penny.
For full year 2012, the company reported adjusted earnings of $4.48 per share compared to $4.05 in the previous year. The adjusted earnings for the year were in sync with the Zacks Consensus Estimate.
Total revenue for fourth quarter 2012 increased 1% year over year to $9.6 billion, exceeding the Zacks Consensus Estimate of $9.5 billion. For full year 2012, sales increased 3% year over year to $37.7 billion as Honeywell continued to benefit from investments in new products and services. At the same time, the company strengthened its key processes, namely Honeywell Operating System, Velocity Product Development, and Functional Transformation to fuel its growth engine. The optimum mix of long- and short-cycle businesses and expansion in high-growth regions also helped to offset lower demand in some of the short-cycle businesses, foreign exchange headwinds, and continued softness in European markets. The company currently has a strong long-cycle order backlog of $15.8 billion.
Segment Performance
Aerospace segment sales dipped 1% year over year to $3.0 billion primarily due to a 6% decline in Defense and Space business. However, segment profit increased 5% year over year to $601 million on the back of commercial excellence and superior productivity net of inflation.
Automation and Control Solutions segment sales were $4.2 billion in the reported quarter, representing a 3% year over year growth, mostly led by volume increase and accretive acquisitions. Segment profit surged 10% to $645 million on the back of commercial excellence and superior productivity net of inflation.
Transportation Systems segment revenue of $844 million for the quarter declined 11% year over year due to lower European light vehicle production and aftermarket sales volume. In addition, segment profit plummeted 20% year over year to $94 million primarily driven by lower sales volumes and price and adverse foreign translation effects.
Performance Materials and Technologies segment sales increased 8% during the quarter to $1.5 billion due to accretive acquisition. However, segment profit decreased 6% to $210 million due to unfavorable price spread in Resins and Chemicals and continued challenging end-market conditions.
Balance Sheet
Cash and cash equivalents were $4.6 billion at year-end 2012 compared to $3.7 billion in the prior-year period. Long-term debt improved marginally to $6.4 billion from $6.9 billion in 2011.
Outlook
With strong quarterly and full year results, Honeywell has reiterated its earnings and revenue guidance for full year 2013. The company expects total revenue of $39.0 billion to $39.5 billion in 2013. Earnings are expected to be in the range of $4.75 to $4.95 per share.
We remain encouraged by the steady performance of the company in the quarter. However, Honeywell needs to be wary of tough competition from its rivals such as Johnson Controls Inc. ( JCI - Analyst Report ) , BorgWarner Inc. ( BWA - Analyst Report ) , and United Technologies Corp. ( UTX - Analyst Report ) . Honeywell currently has a Zacks Rank #3 (Hold).
Read the full reports :
Analyst Report on HON
Analyst Report on JCI
Analyst Report on BWA
Analyst Report on UTX